BioTime’s (NYSE Amex: BTX) OrthoCyte demonstrates Isolating and Expanding Cartilage-Producing Cells from hESC
First demonstration of a scalable source of highly purified and identified progenitor cells Read more…
First demonstration of a scalable source of highly purified and identified progenitor cells Read more…
Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Read more…
End of Day, Cause and Effect Read more…
MultiStem administration provides Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
Acquisition will integrate GeneCards^® Read more…
End of Day, Cause and Effect Read more…
The 6 W’s: Who, what, where, when, why and what of it … Read more…
End of Day, Cause and Effect Read more…
Venture series A financing from Bay City Capital, LLC Read more…

Founder and Director of Research, Henry McCusker enters his eighth (8) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.
I started this blog to add commentary, update news flow and insightful opinions that are intelligent, fit to print and SEC compliant.